• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[庞贝氏病。第一部分:发病机制与临床特征]

[Pompe's disease. Part I: pathogenesis and clinical features].

作者信息

Illés Zsolt, Trauninger Anita

机构信息

Pécsi Tudományegyetem, Neurológiai Klinika.

出版信息

Ideggyogy Sz. 2009 Jul 30;62(7-8):231-43.

PMID:19685701
Abstract

Pompe's disease is an ultra-orphan disease caused by the deficiency of lysosomal alpha-glucosidase. At present, it is the only inherited muscle disorder, which can be treated by replacement of the enzyme. According to the natural course, early infantile and late childhood-juvenile-adult cases are known. Respiratory insufficiency, cardiomyopathy, and muscle hypotonia are cardinal symptoms/signs in infantile Pompe's disease, while cardiomyopathy is absent in adult-onset cases. CK levels are always elevated in the sera of infantile patients. Hip-girdle dystrophy and orthopnoe should alert suspicion in adult patients. Diagnosis is established by decreased activity of the enzyme or mutational analysis. Muscle biopsy can be misleading in adult cases due to absence of glycogen in the examined specimen. In this review, we also discuss our experiences obtained by the treatment of three patients.

摘要

庞贝氏病是一种由溶酶体α-葡萄糖苷酶缺乏引起的超罕见疾病。目前,它是唯一一种可通过酶替代疗法治疗的遗传性肌肉疾病。根据自然病程,可分为早发型婴儿型和晚发型儿童-青少年-成人型病例。呼吸功能不全、心肌病和肌张力减退是婴儿型庞贝氏病的主要症状/体征,而成人发病型病例不存在心肌病。婴儿型患者血清中的肌酸激酶(CK)水平总是升高。髋带肌营养不良和端坐呼吸应引起成年患者的怀疑。通过酶活性降低或突变分析来确诊。在成人病例中,由于所检查标本中缺乏糖原,肌肉活检可能会产生误导。在本综述中,我们还讨论了治疗三名患者所获得的经验。

相似文献

1
[Pompe's disease. Part I: pathogenesis and clinical features].[庞贝氏病。第一部分:发病机制与临床特征]
Ideggyogy Sz. 2009 Jul 30;62(7-8):231-43.
2
[Pompe's disease. Part II. Treatment strategies and enzyme replacement].庞贝氏病。第二部分。治疗策略与酶替代疗法
Ideggyogy Sz. 2009 Sep 30;62(9-10):299-307.
3
[A retrospective study of six patients with late-onset Pompe disease].六例晚发型庞贝病患者的回顾性研究
Rev Neurol (Paris). 2008 Apr;164(4):336-42. doi: 10.1016/j.neurol.2007.09.008.
4
[Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease].[三例患有肥厚型心肌病的低渗性新生儿:庞贝病]
Ned Tijdschr Geneeskd. 1998 Jun 13;142(24):1388-92.
5
[Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease].[匈牙利庞贝病患者酶替代疗法的临床表现、病程及结局]
Orv Hetil. 2011 Sep 25;152(39):1569-75. doi: 10.1556/OH.2011.29184.
6
[Enzyme replacement therapy in Pompe's disease].[庞贝氏病的酶替代疗法]
Med Klin (Munich). 2007 Jul 15;102(7):570-3. doi: 10.1007/s00063-007-1070-z.
7
Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy.接受酶替代疗法的婴儿型庞贝病患者肌肉组织的形态学变化。
Muscle Nerve. 2003 Jun;27(6):743-51. doi: 10.1002/mus.10381.
8
[Late infantile form of Pompe's disease. Deficiency of alpha-1,4-glucosidase (acid maltase)].[庞贝氏病的晚婴型。α-1,4-葡萄糖苷酶(酸性麦芽糖酶)缺乏症]
An Esp Pediatr. 1984 Sep 15;21(3):250-9.
9
Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.晚发型庞贝氏病的酶替代疗法:三年随访
Ann Neurol. 2004 Apr;55(4):495-502. doi: 10.1002/ana.20019.
10
Late-onset Pompe's disease.迟发性庞贝病。
Semin Neurol. 2012 Nov;32(5):506-11. doi: 10.1055/s-0033-1334469. Epub 2013 May 15.